Drugs.com

SEPTEMBER 14, 2024

SATURDAY, Sept. 14, 2024 -- Beans may sometimes give you gas, but one expert says that shouldn't stop you from finding ways to include them in your diet.Why? Because they are packed with nutrients that contribute to good health.“Beans are in a u.

98

98

Covalent Modifiers

SEPTEMBER 14, 2024

Dong, S., Huang, H., Li, J. et al. Commun Chem 7 , 201 (2024). [link] Multi-functional cysteine-targeting covalent warheads possess significant therapeutic potential in medicinal chemistry and chemical biology. Herein, we present novel unsaturated and asymmetric ketone (oxazolinosene) scaffolds that selectively conjugate cysteine residues of peptides and bovine serum albumin under normal physiological conditions.

77

77

BioPharma Drive: Drug Pricing

SEPTEMBER 14, 2024

Results presented at ESMO showed tumor response rates that matched the bar set by analysts for success. But they may not yet be enough to dispel doubts around TIGIT as a target.

Trials 70

Trials Drugs 70

Common Sense for Drug Policy Blog

SEPTEMBER 14, 2024

Deaths in the US Due to the Toxic Unregulated Drug Supply and Overdose, 1999-2023 dwf_admin Sat, 09/14/2024 - 07:58

Drugs 52

Drugs 52

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Treatment

New Drug Approvals

SEPTEMBER 14, 2024

Zamaporvint RXC004, PHASE 2 1H-IMIDAZOLE-1-ACETAMIDE, 5-METHYL-N-(5-(2-PYRAZINYL)-2-PYRIDINYL)-4-(2-(TRIFLUOROMETHYL)-4-PYRIDINYL)- 5-METHYL-N-(5-(2-PYRAZINYL)-2-PYRIDINYL)-4-(2-(TRIFLUOROMETHYL)-4-PYRIDINYL)-1H-IMIDAZOLE-1-ACETAMIDE UNII M56M7CHN8E Molecular Weight 439.39 Formula C 21 H 16 F 3 N 7 O CAS No. 1900754-56-4 Zamaporvint (RXC004) is an orally active and selective inhibitor of Wnt.

Pharmacokinetics 57

Pharmacokinetics Research Drugs 57